Skip to main content

MDS Proteomics Deploys TurboWorx Software

NEW YORK, Feb. 16 (GenomeWeb News) - MDS Proteomics said today that it has purchased software from TurboWorx to automate its analytical processing workflows and integrate its data and applications.

Financial terms of the agreement were not disclosed.

TurboWorx sold a similar system to biotech firm Karo Bio in November.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.